SUGGESTED URL SLUG
aspergillus-niger-osteomyelitis-symptoms-causes-diagnosis
Persistent back pain rarely makes someone think of a fungal infection. Most people assume it is related to muscle strain, poor posture, arthritis, or an underlying spinal condition. Even healthcare professionals are more likely to investigate common musculoskeletal problems or bacterial infections before considering an unusual fungus.
However, in rare circumstances, persistent bone pain may be caused by Aspergillus niger, a mold capable of producing a serious infection known as Aspergillus niger osteomyelitis.
What makes this condition particularly challenging is that its early symptoms may be subtle. Pain can develop gradually, fever may be absent, and routine blood tests do not always reveal how serious the infection has become. Some patients continue experiencing symptoms for weeks or months before the underlying cause is identified.
A published case report from 2024 described a patient with spinal infection caused by Aspergillus niger who experienced persistent pain and developed destructive changes involving several vertebrae. The case highlighted the difficulties of diagnosing uncommon fungal infections, particularly when early investigations do not establish the responsible organism. [1]
Understanding the early symptoms, possible causes, risk factors, and diagnostic challenges of Aspergillus niger osteomyelitis may help patients recognize when persistent pain deserves further medical investigation.
What Is Aspergillus Niger Osteomyelitis?
Aspergillus niger osteomyelitis is a rare fungal infection involving bone tissue. It occurs when the fungus Aspergillus niger enters the body and establishes an infection within the bone.
Osteomyelitis refers to inflammation and infection of bone, most commonly caused by bacteria. Fungal osteomyelitis is considerably less common and may be difficult to recognize because its symptoms often overlap with those of more familiar conditions.
Aspergillus niger belongs to the Aspergillus group of molds found naturally in the environment. These fungi can grow in soil, decaying vegetation, stored organic materials, and other places where moisture and organic matter are present.
People encounter airborne Aspergillus spores regularly, usually without developing an infection. The immune system typically prevents inhaled spores from establishing invasive disease.
In certain circumstances, however, Aspergillus fungi can invade tissues and spread beyond the respiratory tract.
When the infection reaches bone, it may cause inflammation, progressive destruction of bone tissue, and damage to surrounding structures.
Although Aspergillus fumigatus is responsible for most reported Aspergillus bone and joint infections, other species, including Aspergillus niger, have also been implicated. [2]
Why Is Aspergillus Niger Bone Infection So Uncommon?
Most people have effective immune defenses against Aspergillus spores. Invasive infection typically requires conditions that allow the fungus to overcome those defenses.
Furthermore, bone is not the usual site of Aspergillus infection. The respiratory system is more commonly affected because inhalation is an important route of exposure.
For osteomyelitis to develop, the fungus generally must reach bone through the bloodstream, spread from an adjacent infected structure, or enter directly following trauma or a medical procedure.
These circumstances are uncommon, making Aspergillus osteomyelitis a rare diagnosis.
It is important to recognize that much of the available medical evidence concerns Aspergillus osteomyelitis as a group. Information specifically about Aspergillus niger remains limited because relatively few cases have been published.
Early Symptoms of Aspergillus Niger Osteomyelitis
One of the greatest challenges with Aspergillus niger osteomyelitis is that its initial symptoms are not unique to fungal infections.
The symptoms depend on the affected bone, the severity of infection, and whether surrounding nerves, joints, or soft tissues are involved.
1. Persistent Bone Pain That Gradually Gets Worse
Persistent localized pain is one of the most important warning signs of Aspergillus osteomyelitis.
The pain may begin as mild discomfort and gradually become more noticeable. Patients may describe it as a deep ache, pressure, or persistent soreness that does not behave like an ordinary muscle strain.
In a review of 180 patients with Aspergillus osteomyelitis, pain and tenderness were reported in 80% of cases. [3]
Unlike typical muscular discomfort, infection-related bone pain may persist despite rest and conventional pain treatment.
Some patients experience pain during movement, whereas others report discomfort even when resting.
Pain alone cannot establish a diagnosis, but progressive or unexplained pain, particularly in someone with risk factors for fungal infection, deserves careful evaluation.
2. Back Pain That Does Not Improve With Usual Treatment
The spine is one of the most frequently affected locations in Aspergillus osteomyelitis.
When the infection involves the vertebrae, it is called Aspergillus vertebral osteomyelitis. If the intervertebral disc is also infected, the condition may be described as Aspergillus spondylodiscitis.
Symptoms may include:
- Persistent lower or middle back pain.
- Increasing stiffness around the affected spinal region.
- Pain that becomes more noticeable with movement.
- Difficulty standing, walking, or changing positions.
- Localized tenderness over the spine.
In some individuals, the symptoms initially resemble degenerative disc disease, mechanical back pain, or other common spinal disorders.
This similarity can contribute to diagnostic delays.
A 2024 report involving Aspergillus niger described a 63-year-old woman who developed persistent spinal pain that became resistant to commonly used pain medications. Subsequent imaging identified destructive spinal changes involving multiple vertebral levels. [1]
3. Swelling and Tenderness Around the Affected Bone
When Aspergillus osteomyelitis develops in bones closer to the body’s surface, swelling and localized tenderness may become noticeable.
The affected region may feel painful when pressure is applied. Some patients may experience restricted movement or difficulty using the involved limb.
In more advanced cases, infection may extend into nearby soft tissues, potentially producing an abscess.
However, visible swelling is not always present, especially when the infection is deep within the spine or pelvis.
4. Fever May Be Mild or Completely Absent
Many people associate serious infections with high fever, chills, and a feeling of being acutely unwell.
Aspergillus osteomyelitis does not always follow this pattern.
In the 180-patient review, fever was reported in only 22% of patients. [3]
This means that the absence of fever should not automatically exclude a fungal bone infection.
Some patients remain without fever despite significant bone involvement.
This is especially relevant because the clinical evaluation of persistent back pain may initially focus on musculoskeletal causes when fever and other obvious signs of infection are absent.
5. Difficulty Walking or Reduced Mobility
As the infection progresses, pain and inflammation may interfere with everyday movement.
Patients may develop difficulty bearing weight on an affected leg, walking longer distances, bending, or performing activities that were previously comfortable.
When the spine is involved, changes in posture and protective muscle stiffness may further limit mobility.
Advanced infection can also weaken bone, increasing the possibility of structural damage or pathological fracture.
6. Numbness, Tingling, or Weakness
Neurological symptoms are particularly concerning when Aspergillus osteomyelitis affects the vertebrae.
Inflammation, vertebral destruction, or an associated epidural abscess may place pressure on spinal nerves or the spinal cord.
Possible symptoms include numbness, tingling, radiating pain, weakness, and difficulty walking.
A systematic review of Aspergillus osteomyelitis reported substantial rates of spinal cord compression and neurological complications among patients with vertebral involvement. These figures reflect published cases of Aspergillus infection overall, not specifically Aspergillus niger. [3]
New or progressive limb weakness, loss of bladder or bowel control, or numbness around the groin or saddle region requires immediate emergency medical evaluation. These symptoms can indicate serious spinal nerve compression.
What Causes Aspergillus Niger Osteomyelitis?
Aspergillus niger osteomyelitis develops when fungal organisms gain access to bone and establish an invasive infection.
There are three principal routes through which Aspergillus bone infections can occur.
Spread Through the Bloodstream
Aspergillus infection may begin in another part of the body, particularly the lungs.
If fungal organisms enter the bloodstream, they can travel to distant tissues, including bone.
This process is called hematogenous dissemination.
Invasive pulmonary aspergillosis is a recognized concern in patients with severely weakened immune systems. In some cases, infection can extend beyond the lungs and involve the skeleton.
However, not every patient with Aspergillus osteomyelitis has a previously diagnosed lung infection.
Direct Introduction Following Surgery or Injury
The fungus may enter bone tissue directly following certain injuries or medical procedures.
Potential circumstances include open fractures, penetrating trauma, orthopedic surgery, and other invasive procedures involving bone or surrounding tissues.
Such infections are rare, but clinicians may consider fungal causes when bone infection develops after a procedure and conventional treatment does not produce the expected improvement.
In a comprehensive review, a substantial proportion of patients had a history of trauma, open fracture, or surgery. [3]
Spread From Nearby Infected Tissues
Aspergillus infection can also extend from an adjacent infected structure into bone.
For example, infection involving the lungs or surrounding tissues may spread into nearby ribs or vertebrae.
Similarly, certain infections involving the sinuses or neighboring structures may contribute to infection of cranial bones.
The route of spread varies considerably depending on the anatomical location and underlying condition. [4]
Who Is at Greater Risk of Aspergillus Niger Osteomyelitis?
Although this infection is rare, certain medical conditions increase susceptibility to invasive aspergillosis.
People With Weakened Immune Systems
Immunosuppression is an important risk factor.
Individuals at increased risk may include those undergoing chemotherapy, recipients of organ or stem cell transplants, and people with certain immune deficiencies.
Patients receiving prolonged or high-dose corticosteroid treatment may also be more vulnerable.
Corticosteroids can reduce the immune system’s ability to control fungal infections.
People With Diabetes
Diabetes is associated with an increased risk of certain infections, particularly when blood glucose is poorly controlled or other medical problems are present.
Diabetes has also been identified among the underlying conditions reported in patients with Aspergillus osteomyelitis.
However, having diabetes does not mean that persistent bone pain is likely to be caused by Aspergillus.
Because the infection is rare, more common explanations remain considerably more likely.
People With Previous Bone Surgery or Trauma
A history of orthopedic surgery, implanted hardware, open fractures, or significant injury may be relevant when investigating an unexplained bone infection.
Clinicians may need to consider uncommon microorganisms if the infection is persistent, recurrent, or does not respond to standard antimicrobial treatment.
Can Healthy People Develop Aspergillus Niger Osteomyelitis?
Yes. Although invasive Aspergillus infections are more common in immunocompromised patients, osteomyelitis has also been described in individuals without an obvious immune deficiency.
A published 2023 case report documented extensive Aspergillus osteomyelitis involving the pelvis, femur, and vertebrae in a 72-year-old woman without an identified underlying immunodeficiency. She had experienced symptoms for six months before the diagnosis was established. [5]
That report concerned Aspergillus osteomyelitis generally and should not be interpreted as a confirmed Aspergillus niger case.
Nevertheless, it illustrates an important point: the absence of a recognized immune disorder does not completely exclude fungal osteomyelitis.
Why Is Aspergillus Niger Osteomyelitis Often Diagnosed Late?
Delayed diagnosis is one of the most important concerns associated with this rare fungal bone infection.
There is no single reason for the delay. Instead, several clinical and diagnostic challenges may occur together.
The Symptoms Resemble Common Back and Joint Problems
Back pain, stiffness, tenderness, and restricted movement are extremely common symptoms.
They occur with muscle strain, arthritis, degenerative disc disease, fractures, and numerous other conditions.
Because Aspergillus niger osteomyelitis is exceptionally uncommon, clinicians generally investigate more likely causes first.
In the early stages, there may be little to distinguish infection-related pain from ordinary musculoskeletal discomfort.
Fever and Obvious Signs of Infection May Be Missing
The absence of fever can make fungal osteomyelitis particularly difficult to recognize.
Patients may not appear seriously ill, even while infection is gradually damaging bone.
The infection may produce a slow, persistent course rather than the dramatic symptoms commonly associated with acute bacterial infection.
Routine Blood Tests May Not Clearly Identify the Infection
Blood tests can provide useful information, but they cannot reliably establish or exclude Aspergillus osteomyelitis on their own.
Clinicians may request a complete blood count, C-reactive protein, and erythrocyte sedimentation rate to look for evidence of inflammation.
These markers may be elevated, but results vary.
A normal white blood cell count does not exclude fungal osteomyelitis. Inflammatory markers may also be normal or only mildly elevated in some cases.
In the 2024 Aspergillus niger spinal infection report, the patient had a normal C-reactive protein level during part of the diagnostic evaluation despite significant abnormalities on spinal imaging. [1]
This demonstrates why laboratory findings must be interpreted alongside symptoms, examination findings, imaging, and microbiological investigations.
Imaging Findings Can Resemble Other Diseases
Magnetic resonance imaging can reveal abnormalities consistent with osteomyelitis, including bone destruction, inflammation, and involvement of surrounding tissues.
However, imaging alone generally cannot determine which organism is causing the infection.
Fungal osteomyelitis may resemble bacterial infection, spinal tuberculosis, or even malignancy.
This overlap is particularly relevant in regions where tuberculosis is common.
Published reports have described Aspergillus vertebral osteomyelitis presenting with clinical and radiological findings suggestive of spinal tuberculosis. [6]
Initial Biopsy or Culture Results Can Be Negative
One of the most significant diagnostic challenges occurs when the first tissue sample does not identify the infection.
Fungal organisms may not be detected in every specimen.
The amount and location of tissue obtained, sampling limitations, and laboratory processing can influence diagnostic results.
In the 2024 Aspergillus niger case report, the initial spinal biopsy and mycological investigations did not establish a fungal diagnosis. This contributed to the complexity of the patient’s clinical course. [1]
When imaging continues to show progressive infection despite negative initial tests, clinicians may consider repeat sampling or additional investigations.
Fungal Infection May Not Be Considered Early
Because bacterial osteomyelitis is more common, initial diagnostic testing may focus on bacterial organisms.
Fungal testing is especially important when risk factors are present, the disease course is unusual, or infection does not respond as expected to conventional antibacterial treatment.
Failure to identify the specific organism can delay appropriate therapy.
Importantly, negative bacterial cultures do not automatically establish a fungal diagnosis; other infectious and noninfectious causes must also be investigated.
How Is Aspergillus Niger Osteomyelitis Diagnosed?
Diagnosing Aspergillus niger osteomyelitis usually requires a combination of clinical assessment, imaging, and laboratory evaluation.
The goal is not only to establish that bone infection exists but also to identify the organism responsible.
MRI for Suspected Spinal Infection
Magnetic resonance imaging is particularly valuable when vertebral osteomyelitis is suspected.
It can help identify bone marrow abnormalities, intervertebral disc involvement, inflammatory changes, and collections near the spine.
Magnetic resonance imaging may also reveal an epidural abscess or compression of neurological structures.
These findings are important because spinal infection can occasionally threaten nerve function or structural stability.
CT for Bone Destruction
Computed tomography provides detailed images of bone anatomy.
It can help assess bone erosion, vertebral damage, and structural changes associated with infection.
Computed tomography may also be used to guide a needle biopsy toward an abnormal area of bone.
Although imaging is essential for locating and assessing disease, radiological appearances are not sufficient to confirm Aspergillus niger as the cause.
Bone Biopsy and Fungal Culture
Bone biopsy is one of the most important investigations for confirming Aspergillus osteomyelitis.
During a biopsy, a small sample of affected bone or adjacent infected tissue is collected for laboratory examination.
The specimen may be examined using fungal culture and histopathology.
Histopathological examination can identify fungal structures within tissue. Aspergillus species often produce septate hyphae with characteristic branching patterns.
However, the appearance of fungal hyphae alone may not reliably distinguish Aspergillus from certain other molds.
Culture and, when appropriate, molecular testing can help establish the responsible species.
The Infectious Diseases Society of America recommends submitting adequate tissue and fluid specimens for both culture and histopathological evaluation when investigating invasive aspergillosis. [4]
Additional Blood and Fungal Tests
Additional investigations may include inflammatory markers and tests for fungal biomarkers such as galactomannan.
Galactomannan is a component of the Aspergillus cell wall that can sometimes be detected during invasive infection.
However, its diagnostic performance depends on the clinical setting.
A negative blood galactomannan test cannot reliably rule out isolated Aspergillus osteomyelitis, and a positive result alone cannot establish that Aspergillus niger is infecting bone.
Molecular tests may also help identify fungal organisms in selected circumstances.
The choice of testing depends on the patient’s history, imaging findings, immune status, and available laboratory methods.
Aspergillus Niger Osteomyelitis vs. Bacterial Osteomyelitis: Why the Difference Matters
Both fungal and bacterial osteomyelitis can cause persistent bone pain, tenderness, inflammation, and progressive bone damage.
However, identifying the responsible organism is essential because treatment differs.
Bacterial osteomyelitis is generally treated with antibacterial medications selected according to the suspected or confirmed organism.
Aspergillus osteomyelitis requires antifungal treatment.
Conventional antibiotics used against bacteria do not directly treat Aspergillus infection.
In some cases, the condition may initially be treated as bacterial osteomyelitis because the cause remains uncertain.
When symptoms persist, cultures are negative, or imaging demonstrates ongoing destruction, clinicians may need to reconsider the diagnosis.
Importantly, temporary improvement in pain does not necessarily prove that an infection has been eliminated.
Follow-up clinical assessment and appropriate investigations are necessary to determine whether treatment is working.
What Happens if Aspergillus Niger Osteomyelitis Is Left Untreated?
Untreated or inadequately treated Aspergillus osteomyelitis can result in progressive bone destruction and extension into surrounding tissues.
The consequences depend on the affected location and severity of infection.
Potential complications include structural weakening of bone, pathological fractures, persistent pain, abscess formation, and reduced mobility.
When the spine is involved, infection may damage vertebral structures and produce spinal instability.
An epidural abscess or progressive inflammation can compress the spinal cord or nerve roots, potentially causing neurological impairment.
In severe cases, permanent nerve damage may occur.
These complications explain why persistent, unexplained bone pain accompanied by neurological symptoms or concerning imaging findings requires prompt medical attention.
The possibility of serious complications does not mean that every case progresses this way. Early identification and appropriate treatment can substantially improve the opportunity for infection control.
How Is Aspergillus Niger Osteomyelitis Treated?
Treatment is usually managed by specialists in infectious diseases, often working with orthopedic surgeons or spinal surgeons.
The treatment approach depends on the extent of infection, the affected bone, neurological involvement, and the patient’s overall health.
Antifungal Medications
Voriconazole is a commonly recommended antifungal medication for Aspergillus osteomyelitis.
The Infectious Diseases Society of America recommends voriconazole combined with surgical intervention when surgery is feasible and appropriate. [4]
Other antifungal medicines may be considered depending on the organism, susceptibility results, treatment tolerance, and individual circumstances.
Treatment often continues for an extended period.
The 2016 guidelines recommend treating invasive aspergillosis for a minimum of 6 to 12 weeks, depending on the site of disease and the degree of immunosuppression. [4]
There is no single treatment duration suitable for every patient.
Antifungal medications may require monitoring because of potential adverse effects, interactions with other medicines, and variations in drug exposure.
Surgery When Necessary
Surgical treatment may be recommended when infected or damaged tissue needs to be removed, an abscess requires drainage, or neurological structures are threatened.
Surgery may also be necessary when spinal instability or significant compression is present.
However, not every patient requires an operation.
In selected cases without significant instability, neurological compression, or progressive disease, antifungal therapy alone may be considered.
A systematic review of 186 confirmed Aspergillus bone and joint infections found that surgical debridement combined with antifungal treatment was associated with higher rates of complete infection resolution than conservative treatment alone. Because these were largely observational reports, the results should not be interpreted as proving that surgery is necessary for all patients. [2]
Monitoring Recovery
Recovery from fungal osteomyelitis can be prolonged.
Physicians may monitor symptoms, physical function, laboratory findings, medication tolerance, and imaging results where appropriate.
Improvement in pain and mobility can be encouraging, but clinical recovery does not always mean that all radiological abnormalities have disappeared.
Decisions about treatment duration and follow-up should therefore be individualized.
When Should Persistent Bone or Back Pain Raise Concern?
Most cases of back pain are not caused by fungal infection.
Nevertheless, some circumstances warrant additional investigation.
Medical evaluation is particularly important when pain progressively worsens, does not improve with appropriate treatment, or occurs alongside a history of immunosuppression, recent invasive infection, bone surgery, or unexplained inflammatory findings.
Persistent back pain after treatment for an infection also deserves reassessment if symptoms are worsening or recurring.
Patients should tell their healthcare professional about relevant medical history, including transplant medications, chemotherapy, prolonged corticosteroid treatment, or previous fungal infections.
Emergency evaluation is necessary when back pain is accompanied by new weakness, difficulty walking, loss of bladder or bowel control, or numbness in the saddle region.
The purpose of investigating these symptoms is not to assume that Aspergillus niger osteomyelitis is present. Rather, it is to identify or exclude serious causes of pain before avoidable complications develop.
Frequently Asked Questions About Aspergillus Niger Osteomyelitis
Is Aspergillus Niger Osteomyelitis Dangerous?
Yes. Aspergillus niger osteomyelitis can be a serious infection because it may progressively damage bone and nearby tissues.
Spinal involvement is particularly concerning when infection causes abscess formation, instability, or nerve compression.
However, the outcome depends on factors such as the patient’s immune status, extent of disease, and response to treatment. Early diagnosis and appropriate care are important.
What Are the First Signs of Aspergillus Niger Bone Infection?
The earliest noticeable symptom may be persistent localized bone pain or back pain that gradually becomes worse.
Tenderness, stiffness, swelling, or difficulty moving may develop, depending on the affected location.
Fever is not always present, so an absence of fever does not exclude the condition.
Can Aspergillus Niger Cause Spinal Osteomyelitis?
Yes. Published medical literature includes confirmed reports of Aspergillus niger involving the vertebrae and intervertebral discs.
This condition may be described as Aspergillus niger vertebral osteomyelitis or Aspergillus niger spondylodiscitis.
In severe cases, infection can involve adjacent soft tissues or the epidural space. [1]
How Long Can Aspergillus Niger Osteomyelitis Go Undiagnosed?
The duration varies considerably.
Some patients may receive a diagnosis relatively early, while others experience symptoms for weeks or months before fungal infection is identified.
The delay depends on factors such as symptom severity, initial clinical suspicion, access to imaging, and whether tissue testing identifies the organism.
There is insufficient evidence to establish a reliable average diagnostic delay specifically for Aspergillus niger osteomyelitis.
Can Aspergillus Niger Osteomyelitis Occur Without Fever?
Yes. Fever is not a consistent feature of Aspergillus osteomyelitis.
Patients may experience persistent pain and progressive bone abnormalities without developing a high temperature.
This is one reason the infection can be overlooked during the early stages.
Can a Blood Test Detect Aspergillus Niger Osteomyelitis?
Blood tests may support an investigation, but they are not usually sufficient to confirm the diagnosis.
Inflammatory markers and fungal biomarker tests can provide additional information, but their results must be interpreted in context.
A tissue biopsy with fungal culture, histopathology, or appropriate molecular testing is often needed to establish the cause.
Can Aspergillus Niger Osteomyelitis Be Cured?
Successful treatment is possible, but recovery may require prolonged antifungal therapy and, in some cases, surgery.
The outcome depends on the extent of infection, underlying health conditions, potential complications, and response to treatment.
Because infections specifically caused by Aspergillus niger are uncommon, published evidence is insufficient to provide a reliable species-specific cure rate.
Is Aspergillus Niger Osteomyelitis Contagious?
Aspergillus osteomyelitis is not generally considered contagious through ordinary person-to-person contact.
Aspergillus organisms are commonly found in the environment, and infections usually develop following environmental exposure or through routes associated with invasive infection.
The presence of Aspergillus spores in the environment does not mean that a person will develop osteomyelitis.
Can Aspergillus Niger Osteomyelitis Be Mistaken for Tuberculosis?
Yes. Aspergillus vertebral osteomyelitis can resemble spinal tuberculosis because both conditions may produce chronic back pain and destructive changes involving vertebral structures.
Imaging findings alone may not reliably distinguish the infections.
Microbiological and histopathological testing is important because their treatments differ substantially. [6]
Final Thoughts
Aspergillus niger osteomyelitis is a rare but potentially serious fungal bone infection that can be difficult to identify during its early stages.
Persistent pain may be the first and most noticeable symptom, while fever and other familiar signs of infection may be absent. Routine laboratory investigations may also fail to clearly establish the diagnosis.
Because the condition can resemble degenerative spinal disease, bacterial osteomyelitis, tuberculosis, or other bone disorders, diagnosis may be delayed until more targeted investigations are performed.
Magnetic resonance imaging and other imaging studies can help identify suspicious changes, but examination of infected tissue is often essential for confirming the responsible organism.
The most important message is that persistent or progressive bone pain should not automatically be dismissed when symptoms, risk factors, or imaging findings suggest something more serious.
Although Aspergillus niger osteomyelitis is uncommon, recognizing the possibility of a fungal infection in the appropriate clinical setting can help support timely diagnosis, appropriate treatment, and prevention of potentially serious complications.
- Borni M, Kammoun B, Elleuch Kammoun E, Boudawara MZ. A case of invasive Aspergillus niger spondylodiscitis with epidural abscess following COVID-19 infection in an immunocompromised host with literature review. Annals of Medicine and Surgery. 2024;86(11):6846-6853. DOI: 10.1097/MS9.0000000000002610. Full-text article.
- Tsantes AG, Papadopoulos DV, Markou E, et al. Aspergillus spp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases. Medical Mycology. 2022;60(8):myac052. DOI: 10.1093/mmy/myac052. Full-text systematic review.
- Gamaletsou MN, Rammaert B, Bueno MA, et al. Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. Journal of Infection. 2014;68(5):478-493. DOI: 10.1016/j.jinf.2013.12.008. Full-text review.
- Patterson TF, Thompson GR III, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;63(4):e1-e60. DOI: 10.1093/cid/ciw326. Clinical practice guidelines.
- Singh R, Delair A, Kaur S, Gupta M. Neglected extensive Aspergillus osteomyelitis of the pelvis, femur, and vertebra in an immunocompetent patient: A case report. Qatar Medical Journal. 2023;2023(3):25. DOI: 10.5339/qmj.2023.25. Full-text case report.
- Sethi S, Siraj F, Kalra K, Chopra P. Aspergillus vertebral osteomyelitis in immunocompetent patients. Indian Journal of Orthopaedics. 2012;46(2):246-250. DOI: 10.4103/0019-5413.93693. PubMed record.
- Infectious Diseases Society of America. Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. 2015. Clinical guidelines.
Medical disclaimer: This article is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Patients with persistent unexplained bone pain or symptoms of neurological impairment should seek appropriate medical evaluation.
